This would have to be the most compelling insight thus far in regards to potential for FebriDX in the US market. As long as the US-specific waivers and rebates have the effect we hope they do, then US distribution agreements and then forthcoming 2024 sales will be very, very interesting. GLTAH.
Ann: Change in substantial holding, page-72
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
-0.001(2.63%) |
Mkt cap ! $20.83M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $33.89K | 909.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 857775 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 226848 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| LDX (ASX) Chart |